Tatva Chintan Pharma Chem: December ’21 Results Update
Moneylife Digital Team 19 January 2022
Indian specialty chemicals industry is passing through the most exciting phase remarked Chinatan Shah, managing director (MD) of Tatva Chintan Pharma Chem (Tatva) in his opening remarks at Q3FY21-22 earnings call. We had earlier written about Tatva here. While Tatva’s revenue jumped by 31% y-o-y (year-on-year), it witnessed a sequential decline of 15% to Rs105 crore. The decline was...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
Already a subscriber ? Log in
Free Helpline
Legal Credit